Description: Genomictree Inc., a biomarker-based molecular diagnostics company, develops and commercializes molecular diagnostic products for the detection of cancer and various infectious diseases. The company offers EarlyTect C, a screening method for early diagnosis of colorectal cancer; EarlyTect L for detection of epigenetic markers associated with lung cancer in pulmonary nodule patients; and EarlyTect B for detection of genetic and epigenetic markers associated with bladder cancer in hematuria patients. It also provides AccuraDTect SARS-CoV-2 RT-qPCR kits, test providers, and nucleic acid transport medium products. The company was founded in 2000 and is headquartered in Daejeon, South Korea.
Home Page: genomictree.com
44-6 Techno 10-ro
Daejeon,
34027
South Korea
Phone:
82 4 2861 4551
Officers
Name | Title |
---|---|
Dr. Sung-Whan An | CEO & President |
Hong Sun Lee | Head of Management Support Headquarters & CFO |
Mr. Chi-Wang Yoon | COO & VP |
Dr. Tae-Jeong Oh Ph.D. | Head of R&D Division |
Un Lee Yong | Executive Director of Commercial Operations |
Soon Kim Myung | Head of Molecular Diagnostic Lab |
Exchange: KQ
Country: KR : Korea (Republic of)
Currency: Korean Won (₩)
GIC Sector: | Energy |
---|---|
GIC Group: | Energy |
GIC Industry: | Oil, Gas & Consumable Fuels |
GIC Sub-Industry: | Coal & Consumable Fuels |
Forward PE: | 0 |
---|---|
Trailing PE: | 0 |
Price-to-Book MRQ: | 3.9338 |
Price-to-Sales TTM: | 231.8566 |
IPO Date: | |
Fiscal Year End: | December |
Full Time Employees: | 81 |